MARLBOROUGH, Mass.,
Nov. 16, 2015 /PRNewswire/
-- Hologic, Inc. (Nasdaq: HOLX) announced today that the
market research firm KLAS ranked Hologic products highest in the
mammography category in its annual "Best in KLAS" awards. The
ranking is based on the results of an independent survey of
healthcare executives and clinicians by KLAS. It is the sixth
consecutive year that Hologic has achieved the top rating in
mammography.
"Customers say it is hard to find a weakness with Hologic," KLAS
said in their 2015 Best in KLAS report. "Ninety-seven percent of
respondents say they would buy the (Hologic mammography) product
again. Product quality and support both rate high, and
providers see Hologic as the innovator in mammography. A few
say Hologic can be expensive, but that the value received is worth
the money spent."
The annual Best in KLAS: Medical Equipment awards are based on
U.S. healthcare provider evaluations of 14 categories of medical
imaging and pharmacy automation equipment. Hologic
mammography products scored highest in the mammography category,
and highest of all the product categories evaluated.
"Hologic's Genius™ 3D MAMMOGRAPHY™ exams are a revolutionary
advance in breast cancer screening and diagnosis," said
Pete Valenti, Hologic's Division
President, Breast and Skeletal Health Solutions. "Genius 3D™
exams are clinically proven to increase invasive cancer detection
while simultaneously reducing anxiety provoking recalls – an
enormous benefit to patients and healthcare systems
worldwide[i]. Beyond these clinical advantages is
an unwavering commitment to our customers. Hologic strives to
deliver unmatched total value – from national patient education
campaigns to expanding insurance coverage to unmatched service and
support – and we are pleased that our customers understand and
appreciate the value that comes from partnering with us."
In a women's imaging report issued in August, KLAS noted that
mammography providers scored Hologic highest in all 11 performance
measures evaluated.[ii] The report noted that
there is significant movement in the mammography space thanks to
the advent of breast tomosynthesis technology. Sixty-five
percent of the providers surveyed by KLAS planned to invest in
breast tomosynthesis technology during the next two years, up from
57% in 2014.
Additional information about Genius 3D MAMMOGRAPHY™, as well as
a site finder, is available by clicking on
http://mygenius3d.com/find-a-facility/.
About KLAS
KLAS is a healthcare technology research firm that specializes
in monitoring and reporting the performance of software, services,
medical equipment and infrastructure vendors. Working with
thousands of healthcare executives from hospitals and clinics
worldwide, KLAS collects performance feedback to deliver timely
reports, trends and statistics that provide a solid overview of
vendor performance in the industry.
About Hologic
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems and
surgical products. The Company's core business units focus on
diagnostics, breast health, GYN surgical and skeletal health.
With a unified suite of technologies and a robust research and
development program, Hologic is dedicated to The Science of
Sure. For more information on Hologic, visit
www.hologic.com.
Hologic, 3D, 3D Mammography, Dimensions, Genius, The Science of
Sure, and Selenia are trademarks and/or registered trademarks of
Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic digital mammography systems. There can be no
assurance the systems will achieve the benefits described here, or
that such benefits will be replicated in any particular manner with
respect to an individual patient. The actual effect of the
use of the systems can only be determined on a case-by-case basis
depending on the particular circumstances and patient in
question. In addition, there can be no assurance that the
products mentioned will achieve any expected level of sales.
Hologic expressly disclaims any obligation to release publicly any
updates to the data or statements presented here to reflect any
change in the Company's expectations or any change in events,
conditions or circumstances on which any such data or statements
are based.
Contacts
Media
Jim Culley,
PhD
Senior Director, Corporate Communications
302-528-1312
jim.culley@hologic.com
Investors
Michael
Watts
Vice President, Investor Relations and Corporate Communications
858-410-8588
michael.watts@hologic.com
____________________________
|
[i]
Friedewald, SM, Rafferty EA, et.al. Breast cancer screening
using tomosynthesis in combination with digital mammography. JAMA.
2014 Jun 25;311(24):2499-507. doi: 10.1001/jama.2014.6095. Genius™
3D MAMMOGRAPHY™ exams are only available on the Hologic Selenia®
Dimensions® breast tomosynthesis system.
|
[ii]
Women's Imaging. Are the New Technologies Delivering Promised
Benefits? August 2015. Performance Report." © 2015 KLAS
Enterprises, LLC. All rights reserved.
www.KLASresearch.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hologic-ranks-first-in-mammography-category-six-years-running-says-annual-best-in-klas-survey-of-us-healthcare-providers-300179437.html
SOURCE Hologic, Inc.